Senior Brand Manager, Oncology (m/f/d) at Bristol-Myers Squibb

Munich, Bavaria, Germany

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, OncologyIndustries

Requirements

  • Natural science and/or Business Administration degree
  • Experience in pharmaceutical marketing and sales in Oncology or Specialty care (advantage)
  • Experience with performance marketing preferred; capability and willingness for data driven decision making and strategy & execution
  • Experience with omnichannel marketing and implementation of customer journeys
  • Able to translate strong analytical skills into a targeted strategy
  • Excellent project management skills
  • Passionate, curious, creative and well-organized team player
  • Independent way of working, strong business acumen and open-minded
  • Highly energetic, self-reliant, able to successfully drive performance and deliver results
  • Fluency in English and German, both oral and written communications
  • Very good knowledge of the current MS Office applications
  • Strong identification with the company’s values

Responsibilities

  • Develop strategic brand planning for a product in lung cancer / Oncology
  • Develop, coordinate and implement creative and innovative marketing strategies and corresponding activities according to local market requirements
  • Support bottom-up budget planning and manage marketing budget
  • Track brand performance
  • Optimize customer experience and build customer journeys in x-functional collaboration; drive customer engagement by considering both F2F and remote/ digital channels; work closely with Customer Experience Managers and Omnichannel Managers to optimize content placement
  • Content creation according to strategy and based on the customer journey plan
  • Generate insights from market data / intelligence with strong external focus and incorporate findings into strategy, implementation and daily work
  • Regularly seeking feedback, inspiring and train the sales force to enable maximization of the brand potential
  • Close and trustful collaboration with the cross-functional brand team, vendors, external stakeholders and thought leaders

Skills

Brand Planning
Marketing Strategy
Oncology Marketing
Budget Management
Customer Journey Mapping
Cross-Functional Collaboration
Sales Force Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI